TABLE 2.
Sensitivity and specificity of the ACT assay performed on USs and FCU according to presence (+) or absence (−) of symptoms
| Specimen | Presence of symptoms | Sensitivity
|
Specificity
|
||||
|---|---|---|---|---|---|---|---|
| % | No. identified/no. total | 95% CIa | % | No. identified/no. total | 95% CIa | ||
| US | + | 96.5 | 136/141 | 91.9-98.8 | 95.9 | 417/435 | 93.5-97.5 |
| − | 98.9 | 94/95 | 94.3-100 | 97.5 | 634/650 | 96.0-98.6 | |
| Both | 97.5 | 230/236 | 94.5-99.1 | 96.9 | 1,051/1,085 | 95.6-97.8 | |
| FCU | + | 94.3 | 133/141 | 89.1-97.5 | 98.2 | 427/435 | 96.4-99.2 |
| − | 98.9 | 94/95 | 94.3-100 | 98 | 638/657 | 96.6-98.9 | |
| Both | 96.2 | 227/236 | 92.9-98.2 | 98.1 | 1,065/1,086 | 97.1-98.8 | |
CI, confidence interval.